ES2408932T3 - Síntesis y uso de agentes antibacterianos heterocíclicos - Google Patents

Síntesis y uso de agentes antibacterianos heterocíclicos Download PDF

Info

Publication number
ES2408932T3
ES2408932T3 ES09770902T ES09770902T ES2408932T3 ES 2408932 T3 ES2408932 T3 ES 2408932T3 ES 09770902 T ES09770902 T ES 09770902T ES 09770902 T ES09770902 T ES 09770902T ES 2408932 T3 ES2408932 T3 ES 2408932T3
Authority
ES
Spain
Prior art keywords
phenyl
compound
substituted
formula
ethynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09770902T
Other languages
English (en)
Spanish (es)
Inventor
Panduranga Adulla P. Reddy
Umar Faruk Mansoor
M. Arshad Siddiqui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2408932T3 publication Critical patent/ES2408932T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
ES09770902T 2008-06-25 2009-06-24 Síntesis y uso de agentes antibacterianos heterocíclicos Active ES2408932T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7538308P 2008-06-25 2008-06-25
US75383 2008-06-25
PCT/US2009/048368 WO2009158369A1 (en) 2008-06-25 2009-06-24 Synthesis and use of heterocyclic antibacterial agents

Publications (1)

Publication Number Publication Date
ES2408932T3 true ES2408932T3 (es) 2013-06-24

Family

ID=41059643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09770902T Active ES2408932T3 (es) 2008-06-25 2009-06-24 Síntesis y uso de agentes antibacterianos heterocíclicos

Country Status (6)

Country Link
US (1) US20110212078A1 (enExample)
EP (1) EP2307365B1 (enExample)
JP (1) JP2011525927A (enExample)
CA (1) CA2728210A1 (enExample)
ES (1) ES2408932T3 (enExample)
WO (1) WO2009158369A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201716375A (zh) 2007-06-12 2017-05-16 Achaogen Inc 抗菌劑
US9738604B2 (en) 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
WO2015024021A2 (en) 2013-08-16 2015-02-19 Duke University Antibacterial compounds
WO2015024016A2 (en) 2013-08-16 2015-02-19 Duke University 2-piperidinyl substituted n,3-dihydroxybutanamides
AU2014306451B2 (en) 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2017030892A1 (en) 2015-08-14 2017-02-23 Reaction Biology Corp. Histone deacetylase inhibitors and methods for use thereof
WO2017223349A1 (en) 2016-06-23 2017-12-28 Achaogen, Inc. Antibacterial agents
GB2562777A (en) * 2017-05-25 2018-11-28 Taisho Pharmaceutical Co Ltd Novel alpha-amino amide derivatives
TWI774780B (zh) * 2017-06-02 2022-08-21 瑞士商赫孚孟拉羅股份公司 化合物
WO2018220149A1 (en) 2017-06-02 2018-12-06 F. Hoffmann-La Roche Ag Compounds
AU2019294414B2 (en) 2018-06-29 2023-06-29 F. Hoffmann-La Roche Ag Compounds
LT3986897T (lt) 2019-06-21 2023-11-10 F. Hoffmann-La Roche Ag Egfr inhibitorius, skirtas vėžiui gydyti
JP7530390B2 (ja) 2019-06-21 2024-08-07 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト 新規egfr阻害剤
CN110498783A (zh) * 2019-08-02 2019-11-26 成都蓝蜻蜓生物技术有限公司 一种合成罗沙司他中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925659A (en) * 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
AU2594799A (en) * 1998-02-11 1999-08-30 Du Pont Pharmaceuticals Company Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
WO1999041276A1 (en) 1998-02-12 1999-08-19 Molecumetics Ltd. β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF
JP4020290B2 (ja) 2000-09-14 2007-12-12 独立行政法人科学技術振興機構 光学活性ヒドロキサム酸
DE10227464A1 (de) 2002-06-20 2004-01-08 Technische Universität Braunschweig Glaszusammensetzung zur Herstellung von optischen Übertragungselementen
SG2012000667A (en) 2003-01-08 2015-03-30 Univ Washington Antibacterial agents
US7553864B2 (en) 2005-12-01 2009-06-30 Schering Corporation Compounds for the treatment of inflammatory disorders and microbial diseases
JP2010502617A (ja) 2006-08-31 2010-01-28 シェーリング コーポレイション 抗菌物質として有用なヒダントイン誘導体
TW201716375A (zh) * 2007-06-12 2017-05-16 Achaogen Inc 抗菌劑

Also Published As

Publication number Publication date
CA2728210A1 (en) 2009-12-30
EP2307365A1 (en) 2011-04-13
EP2307365B1 (en) 2013-03-27
US20110212078A1 (en) 2011-09-01
WO2009158369A1 (en) 2009-12-30
JP2011525927A (ja) 2011-09-29

Similar Documents

Publication Publication Date Title
ES2408932T3 (es) Síntesis y uso de agentes antibacterianos heterocíclicos
EP2057127B1 (en) Hydantoin derivatives useful as antibacterial agents
US20110212080A1 (en) Urea derivatives as antibacterial agents
ES2924522T3 (es) Inhibidores heteroarilo de PAD4
EP0303697B1 (en) Derivatives of physiologically active substance k-252
ES2211806T3 (es) Derivados beta-carbolina utiles como inhibidores de la fosfodiesterasa.
US7553864B2 (en) Compounds for the treatment of inflammatory disorders and microbial diseases
RU2536865C2 (ru) Производные тиофена
ES2359467T3 (es) Compuestos útiles como inhibidores de proteína quinasas.
CN115835866B (zh) Cereblon结合化合物、其组合物及其用于治疗的方法
ES2816641T3 (es) Derivados de piperidina en calidad de inhibidores de HDAC1/2
CN110770242B (zh) 作为vanin抑制剂的杂芳族化合物
ES2881681T3 (es) 3,4-Dihidro-1H-[1,8]naftiridinonas sustituidas con piperidinilo antibacterianas
BRPI0719861A2 (pt) Compostos heteroaromáticos bicíclicos
CZ61699A3 (cs) N-substituované indol-3-glyoxylamidy s antiastmatickým, antialergickým a imonosupresivním/imunomodulujícím účinkem
KR20030083755A (ko) 동통 치료를 위한 바닐로이드 수용체 길항제로서의 용도를위한 융합 피리딘 유도체
ES2776145T3 (es) 3,4-Dihidro-1h-[1,8]naftiridinonas sustituidas con homopiperidinilo antibacterianas
JP6434528B2 (ja) 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用
ES2303532T3 (es) Nuevos derivados de indol y su uso como medicamentos.
US5574039A (en) Antiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituents
KR20100132553A (ko) 신규한 n-(2-아미노-페닐)-아크릴아미드
ES2981840T3 (es) Derivados de isoquinolina para su uso en el tratamiento del síndrome de deficiencia de GLUT1
PT2094653E (pt) Derivados de o-substituído-dibenzilureia como antagonistas do receptor trpv1
JP2018517720A (ja) 新規ホスホジエステラーゼ5阻害剤とその使用
CS214797B2 (cs) Způsob výroby nových derivátů 4-amino-2-piperidinochinazolinu